Search
for
Sort by
Research 271–300 of 1000+
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
- Skin
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Cutaneous drug reactions
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Vaping Culture and Cutaneous Health: A Trend with Skin-Deep Consequences
- Hair Product Allergy: A Review of Epidemiology and Management
- Hypersensitivity Reactions to Homemade Topical Preparations.
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatological history and examination
- Cutaneous Manifestations of Lupus Erythematosus
- Skin problems in pregnancy
- C001 Lymphoproliferative disorders
- Anthelminthic drugs
- Dermoscopy in General Dermatology: A Practical Overview
- Global Burden of Skin Disease as Reflected in<i>Cochrane Database of Systematic Reviews</i>
- The Spectrum of Skin Disease Among Indian Children
- Quality of Life in Alopecia Areata: A Study of 60 Cases
- Trichoscopy
- Psychodermatology
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non‐depilated mouse model
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- The Association Between Low Grade Systemic Inflammation and Skin Diseases: A Cross-sectional Survey in the Northern Finland Birth Cohort 1966
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia
- Camouflage technique for alopecia areata: What is a patient to do?